Ani Pharmaceuticals (ANIP) Operating Margin Growth (3y) (2015 - 2026)
Ani Pharmaceuticals (ANIP) Operating Margin Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 457.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 457.00 |
| Mar 31, 2026 | 711.00 |
| Dec 31, 2025 | 1,214.00 |
| Sep 30, 2025 | 2,187.00 |
| Jun 30, 2025 | 2,406.00 |
| Mar 31, 2025 | 4,306.00 |
| Dec 31, 2024 | 3,664.00 |
| Sep 30, 2024 | -699.00 |
| Jun 30, 2024 | 3,573.00 |
| Mar 31, 2024 | -1,241.00 |
| Dec 31, 2023 | 453.00 |
| Sep 30, 2023 | 833.00 |
| Jun 30, 2023 | 3,397.00 |
| Mar 31, 2023 | 2,502.00 |
| Dec 31, 2022 | 1,167.00 |
| Sep 30, 2022 | -2,023.00 |
| Jun 30, 2022 | -3,458.00 |
| Mar 31, 2022 | -3,809.00 |
| Dec 31, 2021 | -5,897.00 |
| Sep 30, 2021 | -2,679.00 |